AR035740A1 - Compuestos de etanolato de derivados de guanidina inhibidores del intercambiador de sodio-hidrogeno de tipo 1; composiciones; procedimiento de preparacion y uso en la preparacion de medicamentos - Google Patents
Compuestos de etanolato de derivados de guanidina inhibidores del intercambiador de sodio-hidrogeno de tipo 1; composiciones; procedimiento de preparacion y uso en la preparacion de medicamentosInfo
- Publication number
- AR035740A1 AR035740A1 ARP020100308A ARP020100308A AR035740A1 AR 035740 A1 AR035740 A1 AR 035740A1 AR P020100308 A ARP020100308 A AR P020100308A AR P020100308 A ARP020100308 A AR P020100308A AR 035740 A1 AR035740 A1 AR 035740A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- etanolate
- medicines
- inhibitors
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Etanolatos del inhibidor de NHE-1, N-(5-ciclopropil-1-quinolin-5-il-1H-pirazol-4-carbonil)-guanidina, a formas cristalinas de los etanolatos, a procedimientos para preparar los etanolatos, y a procedimientos de tratamiento que usan los etanolatos y la sal mesilato del inhibidor de NHE-1 preparado usando los etanolatos. Estos compuestos son útiles en la prevención y tratamiento de las lesiones isquémicas de miocardio.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26545601P | 2001-01-31 | 2001-01-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR035740A1 true AR035740A1 (es) | 2004-07-07 |
Family
ID=23010519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020100308A AR035740A1 (es) | 2001-01-31 | 2002-01-29 | Compuestos de etanolato de derivados de guanidina inhibidores del intercambiador de sodio-hidrogeno de tipo 1; composiciones; procedimiento de preparacion y uso en la preparacion de medicamentos |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20020147218A1 (es) |
| EP (1) | EP1355899A1 (es) |
| JP (1) | JP2004518686A (es) |
| KR (1) | KR20030069228A (es) |
| CN (1) | CN1479737A (es) |
| AR (1) | AR035740A1 (es) |
| BR (1) | BR0116841A (es) |
| CA (1) | CA2436539A1 (es) |
| CZ (1) | CZ20032017A3 (es) |
| HU (1) | HUP0302860A2 (es) |
| IL (1) | IL156220A0 (es) |
| MX (1) | MXPA03006872A (es) |
| PL (1) | PL363472A1 (es) |
| RU (1) | RU2242472C1 (es) |
| WO (1) | WO2002060892A1 (es) |
| YU (1) | YU51903A (es) |
| ZA (1) | ZA200303891B (es) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100449600B1 (ko) * | 1998-02-27 | 2004-09-21 | 화이자 프로덕츠 인크. | 허혈 치료용 ｎ-[(치환된 5원 디아자 이불포화 고리)카르보닐] 구아니딘 유도체 |
| US6441176B1 (en) * | 1999-10-29 | 2002-08-27 | Pfizer Inc. | Method for preparing sodium-hydrogen exchanger type 1 inhibitor |
| UA72002C2 (en) * | 1999-10-29 | 2005-01-17 | Pfizer Prod Inc | Inhibitors crystals of sodium-hydrogen exchange of 1 type, a method for the preparation thereof (variants), a pharmaceuticalcomposition based thereon and a method for the reduction of tissue damage |
| CA2407535A1 (en) * | 2000-04-28 | 2001-11-08 | Pfizer Products Inc. | Sodium-hydrogen exchanger type 1 inhibitor (nhe-1) |
-
2001
- 2001-12-21 JP JP2002561041A patent/JP2004518686A/ja active Pending
- 2001-12-21 KR KR10-2003-7010041A patent/KR20030069228A/ko not_active Application Discontinuation
- 2001-12-21 CA CA002436539A patent/CA2436539A1/en not_active Abandoned
- 2001-12-21 PL PL01363472A patent/PL363472A1/xx not_active Application Discontinuation
- 2001-12-21 EP EP01273557A patent/EP1355899A1/en not_active Withdrawn
- 2001-12-21 YU YU51903A patent/YU51903A/sh unknown
- 2001-12-21 BR BR0116841-0A patent/BR0116841A/pt not_active IP Right Cessation
- 2001-12-21 CN CNA018203930A patent/CN1479737A/zh active Pending
- 2001-12-21 MX MXPA03006872A patent/MXPA03006872A/es unknown
- 2001-12-21 HU HU0302860A patent/HUP0302860A2/hu unknown
- 2001-12-21 WO PCT/IB2001/002652 patent/WO2002060892A1/en not_active Application Discontinuation
- 2001-12-21 IL IL15622001A patent/IL156220A0/xx unknown
- 2001-12-21 CZ CZ20032017A patent/CZ20032017A3/cs unknown
- 2001-12-21 RU RU2003123792/04A patent/RU2242472C1/ru not_active IP Right Cessation
-
2002
- 2002-01-29 AR ARP020100308A patent/AR035740A1/es unknown
- 2002-01-30 US US10/060,601 patent/US20020147218A1/en not_active Abandoned
-
2003
- 2003-05-20 ZA ZA200303891A patent/ZA200303891B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2003123792A (ru) | 2005-01-20 |
| IL156220A0 (en) | 2003-12-23 |
| CA2436539A1 (en) | 2002-08-08 |
| WO2002060892A8 (en) | 2003-07-31 |
| PL363472A1 (en) | 2004-11-15 |
| CN1479737A (zh) | 2004-03-03 |
| CZ20032017A3 (cs) | 2004-05-12 |
| US20020147218A1 (en) | 2002-10-10 |
| YU51903A (sh) | 2006-05-25 |
| KR20030069228A (ko) | 2003-08-25 |
| RU2242472C1 (ru) | 2004-12-20 |
| BR0116841A (pt) | 2004-02-25 |
| HUP0302860A2 (hu) | 2003-12-29 |
| JP2004518686A (ja) | 2004-06-24 |
| EP1355899A1 (en) | 2003-10-29 |
| ZA200303891B (en) | 2004-05-20 |
| WO2002060892A1 (en) | 2002-08-08 |
| MXPA03006872A (es) | 2003-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR029766A1 (es) | Compuesto inhibidor de quinasa y uso del mismo para preparar una composicion farmaceutica | |
| ECSP034774A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
| ECSP034773A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
| SE0202463D0 (sv) | Novel compounds | |
| NO20035524D0 (no) | 4'-substituerte nukleosider | |
| NO20021328L (no) | Pyrazolopyrimidier som terapeutiske midler | |
| AR023423A1 (es) | Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos | |
| CO5271715A1 (es) | 7-aza-indolin-2-onas sustituidas en 4 y su uso como inhibidores de proteiuna quinasa | |
| EE200300054A (et) | Kinaasi inhibiitoritena toimivad bitsüklopürasoolid, nende valmistamismeetod, kasutamine ja neid sisaldavad farmatseutilised kompositsioonid | |
| PA8577101A1 (es) | Nuevos derivados de glicosido de tiofeno, procedimientos para la preparacion de los mismos, medicamentos que contienen estos compuestos, y el uso de los mismos | |
| ECSP045253A (es) | Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa | |
| IS6658A (is) | Ný efnasambönd | |
| ES2196377T3 (es) | Derivados de naftiridina. | |
| DK0889877T3 (da) | Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer | |
| DOP2002000422A (es) | Agentes antibacterianos. | |
| UY27424A1 (es) | Agentes antidiabéticos | |
| MX9306311A (es) | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| AR018162A1 (es) | Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica | |
| NO930143L (no) | Piperidinforbindelser, deres fremstilling og bruk | |
| AR030537A1 (es) | Acidos quinolincarboxilicos y naftiridincarboxilico antibacterianos | |
| UY27034A1 (es) | Derivados de pirimidina | |
| AR035740A1 (es) | Compuestos de etanolato de derivados de guanidina inhibidores del intercambiador de sodio-hidrogeno de tipo 1; composiciones; procedimiento de preparacion y uso en la preparacion de medicamentos | |
| CO5261624A1 (es) | Novedosos derivados fenilheteroalquilamina, procesos para su preparacion, composiciones farmaceuticas que comprenden dichos derivados novedosos y su uso en terapia | |
| AR029402A1 (es) | Cristales de inhibidores del intercambiador de sodio-hidrogeno tipo 1, su preparacion, su uso en la fabricacion de medicamentos y composiciones farmaceuticas que los contiene | |
| ES2135351B1 (es) | Derivados de 5-aroilnaftaleno. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |